| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 12/10/2013 | US8603462 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 12/10/2013 | CA2536015C Modified oligonucleotides for telomerase inhibition |
| 12/10/2013 | CA2495411C Real time measurement of cellular responses |
| 12/05/2013 | US20130323722 Methods for High Fidelity Production of Long Nucleic Acid Molecules |
| 12/04/2013 | EP2669377A2 Modified iRNA agents |
| 12/03/2013 | US8598116 Treatment of influenza virus infection |
| 12/03/2013 | US8597893 Human phospholipase A2 epsilon |
| 12/03/2013 | CA2501574C Process for the biological production of 1,3-propanediol with high yield |
| 11/28/2013 | US20130316350 Nucleic acid molecules containing recombination sites and methods of using the same |
| 11/27/2013 | EP2666858A1 Modified iRNA agents |
| 11/26/2013 | US8594762 System for and method of positioning cells and determining cellular activity thereof |
| 11/26/2013 | US8592198 Method for culturing microorganisms on a growth substrate comprising biomass obtained from methanotrophic bacteria |
| 11/26/2013 | US8591894 Humanized antibodies that sequester amyloid beta peptide |
| 11/21/2013 | US20130311202 Methods for Selecting Medications |
| 11/21/2013 | US20130309360 Method for producing ethanol using raw starch |
| 11/20/2013 | EP2664672A1 Modified iRNA agents |
| 11/19/2013 | CA2404890C Rna sequence-specific mediators of rna interference |
| 11/14/2013 | US20130303586 Oligonucleotide compositions with enhanced efficiency |
| 11/14/2013 | US20130302804 Markerless Transformation |
| 11/12/2013 | US8580291 Fibrous composite for tissue engineering |
| 11/07/2013 | WO2002083860A9 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 11/06/2013 | EP2660322A2 Modified iRNA agents |
| 11/06/2013 | EP2659893A2 T cell regulation |
| 11/05/2013 | US8574590 Lipoparticles comprising proteins, methods of making, and using the same |
| 10/31/2013 | WO2003023014A9 Human ion channels |
| 10/31/2013 | US20130288335 Method to improve the stability and broaden the ph range of family g/11 xylanases |
| 10/22/2013 | US8563687 Synthetic genes for plant gums and other hydroxyproline rich glycoproteins |
| 10/22/2013 | CA2505895C Expression profiling based on histocultures |
| 10/22/2013 | CA2474344C Expansion of renewable stem cell populations |
| 10/17/2013 | US20130273654 Generation of Dendritic Cells from Monocytic Dendritic Precursor Cells with GM-CSF in the Absence of Additional Cytokines |
| 10/17/2013 | US20130273626 Regio- and enantioselective alkane hydroxylation with modified cytochrome p450 |
| 10/17/2013 | US20130273047 Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia |
| 10/15/2013 | CA2533926C Methods and compositions for producing antigenic responses |
| 10/09/2013 | EP2261378B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class i membrane fusogenic envelope proteins |
| 10/08/2013 | US8552171 RNA sequence-specific mediators of RNA interference |
| 10/08/2013 | US8551969 Methods to identify compounds useful for tumor sensitization to DNA damage |
| 10/08/2013 | US8551481 Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibody |
| 10/02/2013 | EP2261377B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins |
| 10/01/2013 | US8545838 Compositions and methods for cancer immunotherapy |
| 09/26/2013 | US20130254912 Interferon alpha antibodies and their uses |
| 09/24/2013 | US8541550 Methods and compositions for delivering polynucleotides |
| 09/24/2013 | US8541003 Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| 09/19/2013 | US20130245230 Unnatural Reactive Amino Acid Genetic Code Additions |
| 09/19/2013 | US20130244900 Gene Expression Profiling in Primary Ovarian Serous Papiliary Tumors and Normal Ovarian Epithelum |
| 09/19/2013 | US20130244289 Variant humicola grisea cbh1.1 |
| 09/19/2013 | US20130244256 Compositions and Methods for Treating and Diagnosing Cancer |
| 09/17/2013 | CA2516519C Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/12/2013 | US20130238251 Method and system for detecting discriminatory data patterns in multiple sets of data |
| 09/11/2013 | EP2636302A1 Method for protecting grass using an endophyte |
| 09/11/2013 | CN1906296B Methods for the production of apolipoproteins in transgenic plants |
| 09/11/2013 | CN103289960A 扩展真核生物遗传密码 Extended eukaryotic genetic code |
| 09/10/2013 | US8532937 Methods and systems for identifying micro-RNA targets and synthesizing novel micro-RNAs and uses of the same |
| 09/10/2013 | US8530419 Process for the synchronization of ovulation for timed breeding without heat detection |
| 09/10/2013 | CA2533936C Metabolically engineered bacterial strains having enhanced 2-keto-d-gluconate accumulation |
| 09/05/2013 | US20130230920 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference |
| 09/05/2013 | US20130230862 Methods to identify compounds useful for tumor sensitization to dna damage |
| 09/04/2013 | CN1622995B Receptor nucleic acids and polypeptides |
| 09/03/2013 | US8524948 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 09/03/2013 | US8524899 Alternative heterocycles for DNA recognition |
| 09/03/2013 | US8524672 Method for inhibiting BAFF-R activity |
| 09/03/2013 | US8524368 Charge-dynamic polymers and delivery of anionic compounds |
| 08/29/2013 | US20130224843 Efficient haploid cell sorting flow cytometer systems |
| 08/22/2013 | US20130219536 Lrrk2 polynucleotides and trangenic animals |
| 08/22/2013 | US20130217861 Methods for expression and purification of immunotoxins |
| 08/22/2013 | US20130216566 Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| 08/21/2013 | CN1774511B Fragmentation-based methods and systems for sequence variation detection and discovery |
| 08/15/2013 | US20130212740 Fucosyl transferase gene |
| 08/15/2013 | US20130210673 Polypeptide Display Libraries and Methods of Making and Using Thereof |
| 08/15/2013 | US20130210056 Apparatus for producing high purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
| 08/15/2013 | US20130209996 Method for producing high purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
| 08/15/2013 | US20130206648 Methods and apparatus for producing high purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
| 08/13/2013 | US8507758 Markerless transformation |
| 08/13/2013 | US8507661 Modified iRNA agents |
| 08/13/2013 | US8507266 Apparatus and method for tissue engineering |
| 08/13/2013 | US8507226 Methods for high fidelity production of long nucleic acid molecules |
| 08/13/2013 | US8507198 Compositions and methods of selective nucleic acid isolation |
| 08/08/2013 | US20130203108 Method for producing high purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
| 08/07/2013 | EP2623601A2 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| 08/06/2013 | CA2581363C A reactor and method for solid state fermentation |
| 08/01/2013 | US20130198875 Rna sequence-specific mediators of rna interference |
| 07/30/2013 | US8497082 Composition comprising corn flour and saccharification enzymes |
| 07/30/2013 | US8496961 Delivery of nucleic acid-like compounds |
| 07/30/2013 | CA2605671C Magnetic particles with a glass surface and their use |
| 07/30/2013 | CA2534639C Anti-cd19 antibodies |
| 07/30/2013 | CA2526128C Severe acute respiratory syndrome dna vaccine compositions and methods of use |
| 07/30/2013 | CA2523517C Bcl2l12 polypeptide activators and inhibitors |
| 07/30/2013 | CA2513213C Albumin fusion proteins |
| 07/25/2013 | US20130190221 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 07/25/2013 | US20130189723 Automated cell culture system and process |
| 07/24/2013 | CN1705740B Adenovirus expressing genes in reverse order and use thereof |
| 07/24/2013 | CN103215228A Expanding the eukaryotic genetic code |
| 07/24/2013 | CN103215227A Expanding the eukaryotic genetic code |
| 07/23/2013 | US8492090 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |
| 07/23/2013 | CA2541216C .delta.12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast |
| 07/18/2013 | US20130184629 Skin treatment devices and methods with pre-stressed configurations |
| 07/17/2013 | EP2261380B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins |
| 07/11/2013 | US20130177558 Method of Treating Immunological Disorders by Administering Truncated BAFF Receptors |
| 07/11/2013 | US20130177538 Human lysosomal proteins from plant cell culture |
| 07/10/2013 | EP2261376B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins |
| 07/10/2013 | CN1970571B G-csf analog compositions and methods |